Nuformix is a pharmaceutical development company developing repurposed drugs for fibrosis and oncology
Nuformix is a pharmaceutical development company developing repurposed drugs for fibrosis and oncology. It uses solid-form science to create patented formulations and alternative delivery routes for existing medicines, with an early-stage pipeline including a preclinical inhaled tranilast treatment for idiopathic pulmonary fibrosis. It advances assets toward value inflection points before seeking licensing or partnering deals.